GDC-0941 Inhibits Metastatic Characteristics of Thyroid Carcinomas by Targeting both the Phosphoinositide-3 Kinase (PI3K) and Hypoxia-Inducible Factor-1 alpha (HIF-1 alpha) Pathways

MLA

Sophie Ridsdale, et al. “GDC-0941 Inhibits Metastatic Characteristics of Thyroid Carcinomas by Targeting Both the Phosphoinositide-3 Kinase (PI3K) and Hypoxia-Inducible Factor-1 Alpha (HIF-1 Alpha) Pathways.” The Journal of Clinical Endocrinology & Metabolism, vol. 96, no. 12, Jan. 2011, pp. E1934–43. EBSCOhost, https://doi.org/10.1210/jc.2011-1426.

APA

Sophie Ridsdale, Melissa Mejin, Julia Resch, Emily J. Rowling, Kaye J. Williams, Muhammad Babur, Natalie Burrows, & Georg Brabant. (2011). GDC-0941 Inhibits Metastatic Characteristics of Thyroid Carcinomas by Targeting both the Phosphoinositide-3 Kinase (PI3K) and Hypoxia-Inducible Factor-1 alpha (HIF-1 alpha) Pathways. The Journal of Clinical Endocrinology & Metabolism, 96(12), E1934–E1943. https://doi.org/10.1210/jc.2011-1426

Chicago

Sophie Ridsdale, Melissa Mejin, Julia Resch, Emily J. Rowling, Kaye J. Williams, Muhammad Babur, Natalie Burrows, and Georg Brabant. 2011. “GDC-0941 Inhibits Metastatic Characteristics of Thyroid Carcinomas by Targeting Both the Phosphoinositide-3 Kinase (PI3K) and Hypoxia-Inducible Factor-1 Alpha (HIF-1 Alpha) Pathways.” The Journal of Clinical Endocrinology & Metabolism 96 (12): E1934–43. doi:10.1210/jc.2011-1426.